| Identification | Back Directory | [Name]
CBP-IN-1 | [CAS]
2222941-37-7 | [Synonyms]
CCS147
CCS1477
CCS-1477
CBP-IN-1
CBP inhibitor 1
CCS-1477(CBP-IN-1)
2-Piperidinone, 1-(3,4-difluorophenyl)-6-[5-(3,5-dimethyl-4-isoxazolyl)-1-(trans-4-methoxycyclohexyl)-1H-benzimidazol-2-yl]-, (6S)- | [Molecular Formula]
C30H32F2N4O3 | [MDL Number]
MFCD32062689 | [MOL File]
2222941-37-7.mol | [Molecular Weight]
534.6 |
| Chemical Properties | Back Directory | [Boiling point ]
761.0±60.0 °C(Predicted) | [density ]
1.37±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Ethanol:100.0(Max Conc. mg/mL);187.06(Max Conc. mM) | [form ]
A solid | [pka]
4.40±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
(6S)-1-(3,4-Difluorophenyl)-6-[5-(3,5-dimethyl-4-isoxazolyl)-1-(trans-4-methoxycyclohexyl)-1H-benzimidazol-2-yl]-2-piperidinone is used for the treatment of genetic disease related to the expression of c9orf72 (brain expressed, associated with NEDD4) |
|
|